1 / 3

Hyperlipidemia Drug Market

The global hyperlipidemia drug market is estimated to witness significant growth during the forecast period. The demand for a statin to manage cholesterol is driving the market growth across the globe. This drug supports lowering cholesterol, hence reduce the chances of cardiovascular diseases, stroke, and diabetes. Statins are used to manage the plaque on blood vessels and reduce the risk of blood clots.

nabeelomr
Download Presentation

Hyperlipidemia Drug Market

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. The global hyperlipidemia drug market is estimated to witness significant growth during the forecast period. The demand for a statin to manage cholesterol is driving the market growth across the globe. This drug supports lowering cholesterol, hence reduce the chances of cardiovascular diseases, stroke, and diabetes. Statins are used to manage the plaque on blood vessels and reduce the risk of blood clots. There are various statins options are available in the market for lowering cholesterol levels. Some of the statins used in the US include Atorvastatin (Lipitor), Lovastatin (Altoprev), Pitavastatin (Livalo, Zypitamag), Pravastatin (Pravachol), Rosuvastatin (Crestor, Ezallor), and Simvastatin (Zocor). (Get 15% Discount on Buying this Report) Get Report Sample Copy @https://www.omrglobal.com/request-sample/hyperlipidemia- drug-market Further, according to the American Heart Association (AHA), historical data shows 79.8% of adults who were at least 40 years old use of statins for lowering cholesterol from 2002 to 2013 studies. Such an extensive rise in the number of statinusers is driving the growth of the hyperlipidemia drug market. However, increasing side effects associated withstatin drugs is expected to hinder the growth of the statin drug market. Statins drugs have side effects and some patients are unable to bear it. For instance, atorvastatin and rosuvastatin are high- intensity statins which cause rare side effects like new-onset diabetes and muscle symptoms. A https://www.omrglobal.com/industry-reports/hyperlipidemia-drug-market Full Report of Global IoT Sensors Market is Available at: Hence, the demand for non-statin drugs is expected to contribute to hyperlipidemia drug market growth in the near future. In 2020, the FDA has approved two non-statin drugs after a long period of the last 2 decades. For instance, in February 2020, The FDA approved the first non-statin oral medication for high cholesterol commercialized in the US and around the world. The drug, bempedoic acid, is the first in a new class of drugs to treat low-density-lipoprotein cholesterol. Further, in February 2020, Esperion Therapeutics Inc received FDA approval for its Nexletol, a new type of cholesterol-lowering drug. This drug will help people manage their high cholesterol and reduce the risk of heart diseases. Further, other non-statin drugs for lowering cholesterol include PCSK9-targeting drugs such as Amgen’s Repatha (evolocumab), Sanofi’s Praluent (alirocumab) and inclisiran, developed by Alnylam Pharmaceuticals and The Medicines Company and currently under FDA review. Global Hyperlipidemia Drug Market Segmentation By Drug Class HMG-CoA Reductase Inhibitors (Statins)

  2. PCSK9 Inhibitors Cholesterol Absorption Inhibitors Fabric Acid Derivatives (Fibrates) Niacin (Nicotinic Acid) Bile Acid Sequestrants (BAS) Combination Therapy and Compliance Others Global Hyperlipidemia Drug Market Segmentation by region North America United States Canada Europe UK Germany Italy Spain France Rest of Europe Asia-Pacific China Japan India Rest of the Asia-Pacific Rest of the World Middle East & Africa Latin America Company Profiles Abbott Laboratories Amgen, Inc. AstraZeneca PLC Bristol-Myers Squibb Co.

  3. Daiichi Sankyo Co., Ltd. Dr.Reddy's Laboratories, Ltd. GlaxoSmithKline PLC Reasons to Buying From us – 1. We cover more than 15 major industries, further segmented into more than 90 sectors. 2. More than 120 countries are for analysis. 3. Over 100+ paid data sources mined for investigation. 4. Our expert research analysts answer all your questions before and after purchasing your report. For https://www.omrglobal.com/report-customization/hyperlipidemia-drug-market More Customized Data, Request for Report Customization @ About Orion Market Research Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. Media Contact: Company Name: Orion Market Research Contact Person: Mr. Anurag Tiwari Email: anurag@omrglobal.com Contact no: +91 780-304-0404

More Related